Fjarde Ap Fonden United Therapeutics Corp Transaction History

Fjarde Ap Fonden

$9.04 Billion
Q1 2024

A detailed history of Fjarde Ap Fonden transactions in United Therapeutics Corp stock. As of the latest transaction made, Fjarde Ap Fonden holds 10,800 shares of UTHR stock, worth $4.04 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

10,800

Previous 10,600 1.89%

Holding current value

$4.04 Million

Previous $2.33 Million 6.44%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$210.76 - $249.51 $42,152 - $49,902	200 Added 1.89%	10,800 $2.48 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $408,272 - $488,186	1,900 Added 21.84%	10,600 $2.33 Million
Q3 2023 Oct 23, 2023	SELL	$211.82 - $248.24 $21,182 - $24,824	-100 Reduced 1.14%	8,700 $1.97 Million
Q2 2023 Aug 02, 2023	BUY	$205.19 - $232.99 $205,190 - $232,990	1,000 Added 12.82%	8,800 $1.94 Million
Q1 2023 May 15, 2023	BUY	$212.99 - $276.17 $1.66 Million - $2.15 Million	7,800 New	7,800 $1.75 Million
Q2 2019 Jul 17, 2019	SELL	$76.06 - $120.81 $991,518 - $1.57 Million	-13,036 Closed	0 $0
Q1 2019 Apr 29, 2019	BUY	$107.15 - $126.84 $138,759 - $164,257	1,295 Added 11.03%	13,036 $1.53 Million
Q4 2018 Jan 31, 2019	SELL	$101.4 - $128.73 $324,480 - $411,935	-3,200 Reduced 21.42%	11,741 $1.28 Million
Q2 2018 Jul 12, 2018	BUY	$101.14 - $118.31 $145,338 - $170,011	1,437 Added 10.64%	14,941 $1.69 Million
Q1 2018 May 07, 2018	SELL	$107.21 - $151.94 $42,884 - $60,776	-400 Reduced 2.88%	13,504 $1.52 Million
Q4 2017 Feb 12, 2018	BUY	$118.58 - $151.28 $123,323 - $157,331	1,040 Added 8.08%	13,904 $2.06 Million
Q3 2017 Nov 07, 2017	BUY	$114.6 - $136.81 $11,460 - $13,681	100 Added 0.78%	12,864 $1.51 Million
Q2 2017 Aug 08, 2017	BUY	N/A	12,764	12,764 $1.66 Million

Others Institutions Holding UTHR

# of Institutions

641

Shares Held

45.2M

Call Options Held

368K

Put Options Held

410K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

News

Stay updated on Fjarde Ap Fonden with notifications on news.

Account